FOXO TECHNOLOGIES INC. Investment Company, Redemption Fee, Per Share
FOXO TECHNOLOGIES INC. (FOXO) reported Investment Company, Redemption Fee, Per Share of $0.07 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:InvestmentCompanyRedemptionFeePerShare · last filed 2024-06-06
- FOXO TECHNOLOGIES INC. investment company, redemption fee, per share for fiscal 2023 was $0.07.
| Period end | Investment Company, Redemption Fee, Per Share 6 month | Investment Company, Redemption Fee, Per Share 9 month | Investment Company, Redemption Fee, Per Share 12 month |
|---|---|---|---|
| 2023-12-31 | $0.07 10-K · filed 2024-06-06 | ||
| 2023-09-30 | $0.07 10-Q/A · filed 2024-06-04 | ||
| 2023-06-30 | $0.67 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |